Pacific Edge Confirmed as Approved Provider to Tricare Network in US

The US subsidiary of cancer diagnostics company, Pacific Edge Limited (NZX:PEB), is now an approved provider as part of the TRICARE Health Plan network, which provides healthcare coverage to approximately 9.4 million beneficiaries around the world under the US Military Health System including active military and veterans.

This follows on from the signing of a Federal Supply Schedule in February 2016, which provided Pacific Edge with access to the 10.2 million veterans enrolled in the Veterans Administration as well as access for Cxbladder tests at the 150 US Department of Defence facilities across the United States.

Chief Executive of Pacific Edge, David Darling, said: “We are gaining more and more recognition of our Cxbladder tests as an effective, accurate and simple-to-use, non-invasive test for the diagnosis and monitoring of bladder cancer. This latest provider approval is a reflection of our growing traction in the USA and increases our penetration into this key market.”

Pacific Edge has two of its bladder cancer diagnostic tests available in the USA – Cxbladder Detect and Cxbladder Triage - and expects to launch Cxbladder Monitor in the USA in 2016.